Headlines

Abivax (ABVX FP) CEO says the latest funding round has permitted a move towards launching its bowel disease drug in the US without requiring 3rd party support, CNBC

Newsquawk Staff ·

Abivax (ABVX FP) CEO says the latest funding round has permitted a move towards launching its bowel disease drug in the US without requiring 3rd party support, CNBC.

Related headlines